Epitalon 50mg — Research Protocol Reference

Epitalon is administered once daily via subcutaneous injection in a structured 20-day burst cycle, not continuously.

Evening dosing is strongly preferred, administered 30–60 minutes before bed, as Epitalon's studied effects on pineal melatonin secretion and circadian rhythm restoration are most relevant during the overnight repair window.

Cycle length: 20 days active, 4–6 months rest. Protocol based on Khavinson clinical literature (St. Petersburg Institute of Bioregulation and Gerontology), the most extensively documented longevity peptide research program in the world. Cycles are repeated 2–3 times per year. Continuous daily dosing has not been shown to improve outcomes and is not supported by the research literature.

In biohacking forums, 2mg/day for 20 consecutive days repeated 3x/year is a commonly reported lower-dose alternative. These are community-derived, not clinical. Always complete the standard 20-day cycle first, and keep rest periods at least 4 months before repeating.

Epitalon is administered once daily in the evening, timing the dose before sleep aligns its activity with the pineal gland's natural nocturnal melatonin production window and the body's overnight tissue repair processes.

• Evening, 30–60 minutes before bed: The most widely used timing across both Khavinson's clinical protocols and community use. Epitalon's regulatory effect on melatonin secretion is most active during sleep, and evening dosing positions the peptide's activity to coincide with this window.
• Minimise light exposure after dosing: Blue light from screens suppresses melatonin independently of Epitalon's effect, reducing screen exposure after the evening injection gives the peptide's pineal stimulation the best conditions to work in.
• No gaps mid-cycle: The 20-day active phase requires consecutive daily dosing. Missing days mid-cycle interrupts the telomerase activation and circadian reset signal, complete the full 20 days before stopping.
• Consistent daily timing: Injecting at the same time each evening across the 20-day cycle produces more stable systemic exposure and supports the circadian entrainment mechanism Epitalon has been studied for.
• Respect the rest period: A minimum 4-month gap between cycles is essential. Epitalon's regulatory effects on telomerase and pineal function persist well beyond the dosing period, the rest interval allows those changes to consolidate before the next cycle begins.

The 20-day burst cycle is a fundamental departure from daily-use peptides, two to three short cycles per year, done consistently over multiple years, reflects how the most significant longevity outcomes have been documented in Khavinson's research.

• Do not use continuously: Epitalon is not a daily supplement. Continuous dosing beyond the 20-day cycle has not been shown to improve outcomes and may overstimulate the regulatory pathways the peptide acts on. Two to three cycles per year is the documented approach.
• Evening timing is non-negotiable: Morning dosing misses the pineal melatonin window entirely. Evening administration 30–60 minutes before bed is the only timing supported by the research literature for this peptide.
• The 50mg vial supports multiple cycles: At 5–10mg/day over 20 days, a single 50mg vial covers one full cycle at standard dose or two full cycles at the intro dose. Reconstitute only what you plan to use within 28–30 days, do not reconstitute the full vial if a second cycle is months away.
• Stack considerations: Epitalon pairs well with other longevity-focused peptides, SS-31 targets mitochondria while Epitalon targets telomeres and the pineal gland, covering two distinct mechanisms of biological ageing. Run stack components at their own cycle lengths and do not co-administer at the same injection site.
• Track sleep quality across the cycle: Improvements in sleep depth, dream vividness, and morning energy are among the earliest and most consistently reported subjective responses to Epitalon, tracking these from Day 1 provides the clearest individual signal that the pineal mechanism is responding.

Taking too much Epitalon can increase side effects. Signs your dose may be too high:

• Excessive drowsiness or disrupted sleep architecture: At doses above individual tolerance, Epitalon's effect on melatonin restoration can temporarily over-suppress evening alertness or produce unusually vivid dreams and early waking. Reduce to 5mg/day and hold for the remainder of the cycle.
• Injection site irritation: Persistent redness or swelling beyond 24 hours at the injection site, more likely at higher volumes from 10mg draws, resolves with consistent site rotation and reducing to the previous dose level.
• Mild headache or brain fog: Some users report transient headache or cognitive cloudiness when escalating from 5mg to 10mg too quickly. Hold at 5mg for the first 10 days before increasing, this is built into the protocol structure for this reason.
• Hormonal sensitivity: Epitalon's effect on endocrine regulation can occasionally produce mild hormonal fluctuations, mood shifts or changes in energy rhythm, when the dose exceeds the individual's regulatory threshold. Reduce to 5mg/day for the remainder of the cycle.

If any of these occur, reduce to 5mg/day and complete the cycle at that dose. Do not abandon the cycle mid-run, the telomerase activation signal benefits from the full 20-day duration even at the lower dose.

A dose may be too low if expected effects are absent after the full 20-day cycle. Common indicators:

• No improvement in sleep quality by Week 2: Epitalon's melatonin-restoring effect is typically the earliest response, if sleep depth and quality show no change by Days 10–14, the 5mg intro dose may be insufficient and the 10mg standard dose should be used from Day 11 onward.
• No change in morning energy or recovery across the cycle: A progressive improvement in morning alertness and physical recovery is a consistent marker of Epitalon response. Its absence after a full cycle at 5mg/day suggests the standard 10mg dose is needed on the next cycle.
• No shift in overall vitality or wellbeing after 2–3 cycles: Epitalon's deeper longevity effects, immune modulation, antioxidant defence, telomere support, accumulate across multiple annual cycles. A complete absence of any subjective shift after two to three completed cycles at 5mg/day is a reliable signal to advance to 10mg/day on the next run.

Assess response after each complete 20-day cycle, not mid-cycle. Increase dose only on the next cycle, never mid-run.

⚠️ This is for informational purposes only. For medical advice or diagnosis, consult a professional. ⚠️